HOXB7 and esophageal squamous cell carcinoma: HOXB7 upregulation has been demonstrated in colorectal cancer and esophageal squamous cell carcinoma, and HOXB7 has been shown to indicate poor prognosis in individuals with both these diseases [20, 21].